Fuda Cancer Hospital - Malaysia

Fuda Cancer Hospital - Malaysia Fuda is committed to providing cancer patients around the world with the best medical care. There are totally 400 beds, of which 45 are VIP wards .
(2)

Located in Tianhe District (North Campus) and Haizhu District (South Campus) of Guangzhou City, Fuda Cancer Hospital is under the jurisdiction of Health supervision bureau of Guangdong Province, a bureau that mostly regulates government founded hospitals. Fuda is an affiliated hospital to Jinan University and is the Translational Medicine Center of Guangzhou Institute of Biomedicine and Health of Chinese Academy of Sciences. Fuda operates under the international standards, and was selected as the National Key Clinical Speciality hospital (Oncology) in 2010. Fuda has several highly efficient and professional teams: cryosurgical ablation team, micro-vascular intervention team, immunotherapy team, surgical teams for head-neck, chest and a team for hepato-biliary cancer. The Joint Commission International (JCI), one of the most widely recognized hospital evaluation system, accredited Fuda Cancer Hospital in 2013. In Fuda, we value technology, integrity and humanity. Life is what we hold dear here. Fuda has been providing patients around the world with high-tech, world-class medical services. With all the miracles and success made in the past decade, Fuda is striving to reach the ultimate goal to become a hospital that is specialized in most novel cancer treatment, equipped with advanced medical instrument and focuses on cutting-edge oncological science. In the past decade, Fuda has been using latest cancer-treating technologies to treat patients who were in early or advanced stage of cancer. Fuda's treatment has helped patients by significantly prolonging patient’s survival time and improving life quality. Fuda has developed a unique “3C+P” treatment model, which is, cryosurgical ablation (CSA), CANCER MICRO-VASCULAR INTERVENTION (CMI), COMBINED IMMUNOTHERAPY FOR CANCER (CIC), AND PERSONALIZED TREATMENTS (P). So far, Fuda has had more than 10,000 cases of cryosurgical ablation, which ranks No.1 in the world in terms of quantity as well as the types of cancer treated. Fuda has attracted cancer patients from more than 70 countries around the world, 70 percent of patients from foreign countries in South-East Asia, the Middle East, Oceanic, Europe and North America. Fuda has received various awards in China and abroad for outstanding achievements in treating cancer and been highly praised by patients around the world.

28/01/2026

27/01/2026

【Minimally Invasive Treatment】【Lung Nodule – Cryoablation】
>>>Ablate nodule while chatting: Cryoablation for Lung Nodule> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

【复大新闻】【沙特介入放射学大会】中国治疗方案亮相沙特介入放射学大会2026年1月15日至17日,第九届沙特介入放射学会(SIRS)年度科学大会在沙特阿拉伯首都利雅得举行。来自世界各地的介入放射学领域顶尖专家与学者齐聚一堂。作为国家临床重点...
21/01/2026

【复大新闻】【沙特介入放射学大会】
中国治疗方案亮相沙特介入放射学大会
2026年1月15日至17日,第九届沙特介入放射学会(SIRS)年度科学大会在沙特阿拉伯首都利雅得举行。来自世界各地的介入放射学领域顶尖专家与学者齐聚一堂。作为国家临床重点专科(肿瘤科)医院以及现代化新型肿瘤专科涉外医院,广州复大肿瘤医院应邀参会。医疗专家刘树鹏主任及国际事务总负责人谭翠翠代表医院出席本次盛会。

会上,刘树鹏主任作了《冷冻消融联合PD-1抑制剂及化疗在治疗进展期肺癌中的作用》的主题演讲。他指出,肺癌是全球面临的重大健康挑战,其中非小细胞肺癌约占所有病例的85%。尽管EGFR、ALK等靶向药物的应用显著提升了患者的生存获益,但仍有60%-70%的患者在治疗9-18个月内出现耐药,这成为临床实践中亟待突破的瓶颈。

新兴的治疗方式包括冷冻消融(诱导免疫原性细胞死亡)、PD-1抑制剂(恢复T细胞功能)和化疗(增强抗原暴露),显示出各自治疗潜力。而将三者科学、合理地联合应用,有望为晚期非小细胞肺癌患者开辟一条富有前景的综合治疗路径。演讲中,刘主任通过详实的临床研究数据、清晰的对比图表,对这一联合策略的作用机制、临床疗效及安全性进行了系统阐述与深入分析,其内容扎实、视角前沿,引发了在场专家学者的广泛关注与热烈讨论。

此次分享不仅展示了广州复大肿瘤医院在肺癌综合治疗领域的积极探索与临床成果,也体现了中国肿瘤学界在国际舞台上日益提升的学术影响力。医院将继续秉持创新与开放的态度,推动介入治疗技术与肿瘤综合治疗的融合发展,为更多患者带来生命新希望。

點擊了解更多患者故事
>>> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們:
☎️電話: +60 19 996 4656
🌟Whatsapp: +60 19 996 4656
🌍網站: https://hongkong.fudahospital.com

Fuda News] [Saudi Interventional Radiology Congress]Chinese Treatment Approaches Debut at the Saudi Interventional Radio...
21/01/2026

Fuda News] [Saudi Interventional Radiology Congress]
Chinese Treatment Approaches Debut at the Saudi Interventional Radiology Congress
From January 15 to 17, 2026, the 9th Annual Scientific Congress of the Saudi Interventional Radiology Society (SIRS) was held in Riyadh, the capital of Saudi Arabia. Top experts and scholars in the field of interventional radiology from around the world gathered for this prestigious event. As a National Key Clinical Specialty (Oncology) hospital and a modern international cancer specialty hospital, Guangzhou Fuda Cancer Hospital was invited to attend. Director Liu Shupeng, a medical expert, and Tan Cuicui, Head of International Affairs, represented the hospital at the congress.

At the meeting, Director Liu delivered a keynote speech entitled “The Role of Cryoablation Combined with PD-1 Inhibitors and Chemotherapy in the Treatment of Advanced Lung Cancer.” He pointed out that lung cancer remains a major global health challenge, with non-small cell lung cancer accounting for approximately 85% of all cases. Although targeted therapies such as EGFR and ALK inhibitors have significantly improved patient survival, 60%–70% of patients still develop drug resistance within 9–18 months of treatment, which has become a critical bottleneck in clinical practice.

Emerging treatment approaches, including cryoablation (which induces immunogenic cell death), PD-1 inhibitors (which restore T-cell function), and chemotherapy (which enhances antigen exposure), have each demonstrated therapeutic potential. The rational and scientific combination of these three modalities is expected to open a promising comprehensive treatment pathway for patients with advanced non-small cell lung cancer. During his presentation, Director Liu systematically elaborated on the mechanism of action, clinical efficacy, and safety of this combined strategy through detailed clinical research data and clear comparative charts. His solid content and forward-looking perspective attracted widespread attention and lively discussion among attending experts and scholars.

This presentation not only showcased Guangzhou Fuda Cancer Hospital’s active exploration and clinical achievements in the field of comprehensive lung cancer treatment, but also reflected the growing academic influence of Chinese oncology on the international stage. The hospital will continue to uphold an innovative and open approach, promoting the integrated development of interventional technologies and comprehensive cancer treatment, and bringing new hope to more patients.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

【患者故事】【菲律宾-前列腺癌-锶89】18天增重6公斤!菲籍患者跨海求医,女儿用三个“非常”点赞复大在广州复大肿瘤医院的病房里,来自菲律宾的Jose(化名)半卧在床上。他身形清瘦,却依旧难掩那帅气的气质,眼神中透露出一抹久违的光亮。两个女...
21/01/2026

【患者故事】【菲律宾-前列腺癌-锶89】
18天增重6公斤!菲籍患者跨海求医,女儿用三个“非常”点赞复大
在广州复大肿瘤医院的病房里,来自菲律宾的Jose(化名)半卧在床上。他身形清瘦,却依旧难掩那帅气的气质,眼神中透露出一抹久违的光亮。两个女儿安静地陪在身旁,这般平凡的照料,在几个月前对他们而言,近乎是一种奢望。

“那时候,我觉得自己像一棵蒸过头的蔬菜,软绵绵的,什么也做不了。”Jose用略带口音的英语缓缓说道,“而现在,我可以自理了,能够自己去洗手间了。”
十五年前,Jose因尿频、血尿被确诊为前列腺癌。由于肿瘤太大,无法做根治手术,他只能接受电切术,并长期进行内分泌治疗。让他感到窘迫的是,排尿仍会有些困难,必须佩戴尿管才行。日子在小心翼翼中一天天过去,直到2025年3月,一纸PET-CT检查报告再次打破平静——全身多处骨转移。
颈背部、腰背部的疼痛日益加剧,当地医生给予了唑来膦酸护骨治疗,但肾脏指标的波动提示着肾功能损伤的风险。Jose的女儿们一边照顾父亲,一边在网络上四处寻找新的希望。一条关于广州复大肿瘤医院“冷冻消融技术”的分享,引起了她们的注意。
“我们通过医院的菲律宾服务中心,线上咨询了医疗二科冯锡霖主治医师。”Jose的女儿回忆道,“冯医生详细了解了爸爸的情况,建议我们先调整药物,再做进一步治疗。”
带着一丝忐忑和更多期待,一家人飞越海洋,来到了广州。
初到复大时,Jose的身体非常虚弱,站又站不稳,看又看不清,还伴有低钠血症。“整个人就像垮掉了一样。”医疗二科团队为他进行了全面评估,考虑到他的身体状况,认为他不适合冷冻消融,而是先调整了治疗方案,更换了更适合他的药物。
同时,医生们提出一个对Jose来说很新的治疗方法——锶89。
锶-89,全名氯化锶[⁸⁹Sr]。它是一种放射性药物,进入体内后,会选择性沉积于成骨活跃的骨转移灶处,释放β粒子实现局部照射,从而减轻骨痛。简单来说,它就像是一位拥有“卫星导航”的“特工”,能够精准找到骨转移病灶并实施打击。
Jose决定试一试。
治疗过程并不复杂。结束后,他带着药和一份详细的康复计划,回到了菲律宾。变化,也在不知不觉中发生。
疼痛一天天减轻,食欲慢慢回来。最让他惊喜的是,体重在18天内从45公斤悄悄长回到51公斤。他还能独自起身去洗手间了——而就在不久前,他曾因虚弱在那里摔倒,还磕到头。
复查结果更带来了好消息:肿瘤标志物PSA下降了,前列腺的病灶缩小了,部分骨转移瘤的信号也在减弱。
“我现在吃得可香呢!”视频里,Jose举着一块肉,吃得十分满足。女儿特意录下这一幕,分享给复大的医护人员。

住院期间,每当Jose感到不适或疼痛,医护人员总是第一时间出现,用专业的技术和温暖的态度为他解决问题。女儿们更是用三个“非常”评价复大的医护团队:“非常乐于助人、非常友善、非常及时。”
在复大,Jose还体验了中医。虽然中药的味道让他皱眉头,但身体的好转让他坚持了下来。“良药苦口,这话一点没错。”他甚至对中式推拿产生了兴趣,想要进一步体验。
如今,Jose已经完成了两次锶89治疗。他不把自己看作病人,而是一个仍在享受生活的普通人。而他其中一个女儿,也因为陪伴父亲就医,顺便在复大做了体检,并决定在这里治疗自己的妇科问题。
“复大给我的,不只是一个治疗方案。”Jose说,“而是一次重新开始的机会。他们真的站在病人的角度,为我们寻找最合适的路。”
从菲律宾到广州,从卧床不起到重拾自理,Jose的故事,是关于疼痛过后长出的新芽,更是关于——无论多远,都有人愿意为你,守护生命的温度。

點擊了解更多患者故事
>>> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們:
☎️電話: +60 19 996 4656
🌟Whatsapp: +60 19 996 4656
🌍網站: https://hongkong.fudahospital.com

[Patient Story] [Philippines – Prostate Cancer – Strontium-89]Gained 6 kg in just 18 days! Filipino patient crossed the ...
21/01/2026

[Patient Story] [Philippines – Prostate Cancer – Strontium-89]
Gained 6 kg in just 18 days!

Filipino patient crossed the sea for treatment

In a ward at Guangzhou Fuda Cancer Hospital, Jose (pseudonym) from the Philippines lies half-reclined on his bed. Though thin in appearance, he still carries a handsome charm, and a long-lost sparkle has returned to his eyes. His two daughters sit quietly by his side. Such ordinary companionship had once felt like an impossible luxury to them just a few months ago.

“At that time, I felt like an over-steamed vegetable — soft and weak, unable to do anything,” Jose said slowly in English with a slight accent. “But now, I can take care of myself. I can even go to the bathroom on my own.”

Fifteen years ago, Jose was diagnosed with prostate cancer after experiencing frequent urination and blood in his urine. Because the tumor was too large for radical surgery, he could only undergo transurethral resection and long-term hormone therapy. Even so, urination remained difficult and he had to rely on a catheter.

Life went on cautiously day by day — until March 2025, when a PET-CT scan shattered the fragile calm: multiple bone metastases throughout his body.
Pain in his neck, back, and waist grew worse. Local doctors prescribed zoledronic acid for bone protection, but fluctuating kidney indicators suggested a risk of kidney damage. While caring for their father, Jose’s daughters searched online for new hope. A post about Guangzhou Fuda Cancer Hospital’s cryoablation technology caught their attention.

“We contacted the hospital’s Philippine Service Center and consulted online with Dr. Feng Xilin from the Second Medical Department,” one daughter recalled. “Dr. Feng carefully reviewed my father’s condition and suggested adjusting his medications first before further treatment.”

With a mix of anxiety and hope, the family flew across the sea to Guangzhou.
When Jose first arrived at Fuda, he was extremely weak — unable to stand steadily, with blurred vision, and suffering from hyponatremia. “It felt like my whole body had collapsed,” he said. After a comprehensive evaluation, the medical team decided that he was not suitable for cryoablation at the moment and adjusted his treatment plan with more appropriate medications.

At the same time, doctors introduced him to a new treatment option — Strontium-89.
Strontium-89 (Strontium Chloride [⁸⁹Sr]) is a radioactive drug that selectively accumulates in active bone metastases and releases beta particles to deliver localized radiation, thereby relieving bone pain. In simple terms, it works like a “special agent with satellite navigation,” precisely targeting bone metastases and striking them accurately.
Jose decided to give it a try.
The treatment process was not complicated. Afterward, he returned to the Philippines with medication and a detailed rehabilitation plan. And quietly, change began to happen.

His pain gradually eased. His appetite returned. Most amazingly, his weight increased from 45 kg to 51 kg in just 18 days. He could even get up and go to the bathroom by himself — something he had been unable to do not long before, when he once fell there and hit his head due to weakness.

Follow-up examinations brought more good news: his tumor marker PSA had dropped, the prostate lesion had shrunk, and signals from some bone metastases had weakened.
“I’m eating so well now!” Jose said in a video, holding up a piece of meat with great satisfaction. His daughter recorded the moment and shared it with the medical staff at Fuda.

During his hospitalization, whenever Jose felt unwell or in pain, the medical team always responded immediately, solving problems with professional expertise and warm care. His daughters summed up the Fuda team with three “very’s”:
“Very helpful, very friendly, and very timely.”

At Fuda, Jose also experienced traditional Chinese medicine. Though he frowned at the bitter taste of herbal medicine, the improvement in his condition encouraged him to persist.
“Good medicine tastes bitter — that saying is absolutely true,” he said. He even became interested in Chinese therapeutic massage and wanted to explore it further.

So far, Jose has completed two rounds of Strontium-89 treatment. He no longer sees himself as a patient, but as an ordinary person still enjoying life. One of his daughters, who accompanied him for treatment, also had a health check at Fuda and decided to receive treatment for her own gynecological condition here.
“What Fuda gave me is not just a treatment plan,” Jose said.
“It’s a chance to start over. They truly stand in the patient’s shoes and help us find the most suitable path forward.”

From the Philippines to Guangzhou, from being bedridden to regaining independence — Jose’s story is about new life sprouting after pain, and about this truth:
No matter how far the journey, there will always be people willing to protect the warmth of life for you.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

[Patient Story] [China – Duodenal Adenocarcinoma – Intrathecal Analgesia Pump]A Small Pump Breaks the “Pain Deadlock”: F...
14/01/2026

[Patient Story] [China – Duodenal Adenocarcinoma – Intrathecal Analgesia Pump]
A Small Pump Breaks the “Pain Deadlock”: Fuda’s First Intrathecal Analgesia Pump Brings Precise Pain Relief to Cancer Patients
Cancer pain is one of the most unbearable sufferings for patients with advanced malignancies. It can be severe and persistent day and night, continuously draining a patient’s physical strength, weakening the body’s immune system, and seriously shaking their confidence in fighting the disease and facing life.
Recently, the Sixth Medical Department of Guangzhou Fuda Cancer Hospital successfully performed the hospital’s first intrathecal analgesia pump implantation. By implanting a drug delivery pump, pain can be relieved in a more precise and efficient way, bringing a ray of hope to patients tormented by cancer pain.

Ms. Huang (pseudonym), 63 years old, has been battling duodenal adenocarcinoma for three to four years. Despite undergoing radical surgery, chemotherapy, immunotherapy, and targeted therapy, the tumor continued to progress, invade, and metastasize. Severe cancer pain tortured her day and night. As her condition worsened, she became increasingly exhausted, emotionally unstable, and occasionally delirious. Frequent breakthrough pain made her suffer unbearably. Even with a daily oral dose of OxyContin as high as 520 mg, combined with continuous intravenous morphine infusion and morphine solution, side effects and limited efficacy left her treatment at an impasse.
Facing the limitations of conventional therapies, Director Li Hongmei of the Sixth Medical Department, together with a multidisciplinary team from the Interventional Department, Pain Department, and Anesthesiology Department, designed a breakthrough treatment plan for Ms. Huang — implantation of an Intrathecal Drug Delivery System (IDDS), commonly known as an “intrathecal analgesia pump.”

This advanced technology involves implanting a small infusion pump into the body through a minimally invasive procedure, delivering analgesic drugs directly into the subarachnoid space of the spinal cord. Compared with high-dose oral opioids, this technique offers significant advantages, including lower drug dosage, stronger analgesic effect, fewer side effects, and dynamic dose adjustment. It is especially suitable for patients with advanced cancer pain who respond poorly to conventional three-step analgesic therapy or cannot tolerate drug side effects, greatly improving their quality of life.

After surgery, Ms. Huang experienced excellent pain relief. Her pain is now fully under control, and her quality of life has been effectively safeguarded.
The successful completion of the hospital’s first intrathecal analgesia pump implantation marks a major breakthrough in the treatment of advanced cancer pain. Like a key, it opens a new door of peace and dignity for countless lives locked in by intractable cancer pain. In the future, the hospital will continue to deepen its efforts in pain management, continuously optimize treatment strategies, and bring hope and warmth to more patients.
Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

【患者故事】【中國-結腸癌-臭氧消融】由抗癌到止痛 復大全程守護 贏得七旬「回頭客」信賴「反正生病都要花錢醫,點解唔揀一間令我覺得舒服嘅醫院呢?」今年77歲嘅麥奶奶(化名),啱啱喺廣州復大腫瘤醫院完成咗一次頸椎間盤臭氧消融術。老太太精神奕奕...
09/01/2026

【患者故事】【中國-結腸癌-臭氧消融】
由抗癌到止痛 復大全程守護 贏得七旬「回頭客」信賴
「反正生病都要花錢醫,點解唔揀一間令我覺得舒服嘅醫院呢?」
今年77歲嘅麥奶奶(化名),啱啱喺廣州復大腫瘤醫院完成咗一次頸椎間盤臭氧消融術。老太太精神奕奕,但其實佢已經同癌症對抗咗足足18年,係名副其實嘅「老戰士」。

△ 醫療五科主任劉樹鵬與麥奶奶合影
2007年,麥奶奶因為肚痛檢查出「升結腸癌」,其後喺當地醫院接受過手術、化療、免疫治療等多種方案。不過,疾病後來仍然復發,並出現多處淋巴結轉移。
大醫院人多床緊,睇病往往要等好耐。2022年,經人介紹,麥奶奶嚟到復大醫療五科。當時檢查發現,佢腸道內有一個約2 cm × 2.5 cm、表面凹凸不平、呈菜花狀嘅結節性腫塊,醫生好快就為佢安排切除手術。雖然一個月後因為腸梗阻再入院治療一次,但之後結腸癌一直保持穩定,冇再復發或轉移。
癌症控制住之後,隨住年紀增長,各種老年病亦相繼出現。近幾年,麥奶奶嘅頸、腰同腿經常劇痛,嚴重影響日常生活。佢曾經喺復大中醫科接受針灸、推拿治療,效果維持咗好幾年,但今年就開始難以控制。
進一步檢查顯示,佢嘅頸椎同腰椎多節椎間盤病變明顯,尤其係頸部疼痛突出。醫療五科團隊向佢推薦咗醫院新引入嘅「臭氧消融術」。麥奶奶幾乎冇多諗就答應咗——自2022年起一直喺復大睇病,佢對呢度嘅醫生同護士已經建立咗高度信任。
「佢哋話適合我,我就信佢哋。」佢笑住話。

△ 圖片來源於網絡
臭氧消融術係近年發展迅速嘅微創介入技術,喺DSA、CT等影像設備精準引導下,將醫用臭氧注射入病變椎間盤。臭氧透過氧化、消炎同消融三重作用,快速減輕神經壓迫,促進組織修復。由於具備微創、高效、安全、創傷細等優點,亦被稱為「綠色療法」。
一針臭氧可達到「兩重治療」效果:既能特異性氧化髓核結構,使液化髓核收斂、固化,消除化學性刺激同免疫源性反應,同時亦具備良好嘅消炎止痛作用。當臭氧注射到神經根周圍,神經根性疼痛可即時緩解,隨住時間推移,髓核逐漸萎縮固化,唔再突出。

△ 圖片來源於網絡
手術過程中,副院長商健彪教授喺DSA透視下精準定位,使用21G幼針準確進入頸5/6及頸6/7椎間隙,注入適當濃度嘅臭氧,術口只需貼上創口貼即可。雖然術後需要平躺休息一日,而且頸部唔可以活動,令麥奶奶覺得有啲「辛苦」,但好快佢就感覺到頸痛明顯減輕,整個人都輕鬆咗唔少。
臭氧消融術適應症
臨床症狀明顯,如持續性腰腿痛、間歇性跛行等;
有脊神經受壓體徵或感覺異常,例如直腿抬高試驗陽性;
影像學檢查確診為包容性或單純性椎間盤突出,且影像表現與臨床症狀體徵一致;
經8週以上保守治療效果欠佳;
外科手術或其他椎間盤微創治療效果不理想;
長期保守治療無效嘅腰痛,冇明顯神經壓迫症狀,但影像學證實相應節段存在椎間盤病變(如椎間盤膨出),並已排除其他原因。
「反正都要花錢醫病,點解唔揀一間令我安心、舒服嘅醫院呢?」
多年來幾次住院嘅經歷,令麥奶奶喺復大唔單止得到治療,更感受到關懷同可靠,亦成為佢做「回頭客」嘅原因。
喺復大,麥奶奶嘅故事並非個案。唔少曾經喺呢度戰勝重症嘅患者,當遇到其他健康問題時,仍然選擇返到呢個「熟悉嘅地方」,成為一名「回頭客」。呢份持續嘅信任,構成咗醫患關係嘅良性循環。
由腫瘤治療、老年疼痛管理,到日常康復照護,醫院各科室緊密協作,希望陪伴患者走過人生每一個健康階段。我哋深知,每一次治療,承載嘅都係一段獨一無二嘅生命旅程。醫院唔只係解除病痛嘅技術場所,更應成為守護全生命周期健康嘅可靠夥伴。科室之間嘅協作,唔止於技術,更係對「人」嘅整體關懷。
無論你係初次到訪,定係舊友歸來,呢度始終不變嘅,係以專業為根基、以真誠為承諾嘅守護。願以醫學之精誠,陪伴每一個家庭,安穩走過歲月長河。

點擊了解更多患者故事
>>> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們:
☎️電話: +60 19 996 4656
🌟Whatsapp: +60 19 996 4656
🌍網站: https://hongkong.fudahospital.com

【Patient Story】【China - Colon Cancer - Ozone Ablation】From Fighting Cancer to Relieving Pain: Fuda’s Comprehensive Care ...
09/01/2026

【Patient Story】【China - Colon Cancer - Ozone Ablation】
From Fighting Cancer to Relieving Pain: Fuda’s Comprehensive Care Earns the Trust of 77-Year-Old Patient
“Since I have to spend money on treatment anyway, why not choose a hospital where I feel comfortable?”
This year, 77-year-old Ms. Mai (pseudonym) has just completed a cervical disc ozone ablation procedure at Guangzhou Fuda Cancer Hospital. Energetic and in good spirits, she is in fact a seasoned “veteran” who has been battling cancer for 18 years.

In 2007, Ms. Mai was diagnosed with ascending colon cancer after experiencing abdominal pain. She underwent surgery, chemotherapy, immunotherapy, and other treatments at a local hospital. Unfortunately, the cancer later recurred, accompanied by multiple lymph node metastases.

Large hospitals are often overcrowded, with long waiting times and limited beds. In 2022, upon recommendation, Ms. Mai came to Medical Department V at Fuda Hospital. At that time, examinations revealed a nodular, cauliflower-like mass measuring approximately 2 cm × 2.5 cm with an uneven surface in her intestine. Doctors promptly performed a surgical resection. Although she was readmitted one month later due to intestinal obstruction, her colon cancer has since remained stable, with no further recurrence or metastasis.
While the cancer was under control, age-related conditions gradually emerged. In recent years, Ms. Mai suffered from severe pain in her neck, lower back, and legs, which significantly affected her daily life. She previously received acupuncture and massage therapy at Fuda’s Traditional Chinese Medicine Department, with relief lasting for several years. However, this year the pain became difficult to manage.
Further examinations showed prominent disc degeneration in both her cervical and lumbar spine, with particularly severe neck pain. The Medical Department V team recommended the hospital’s newly introduced ozone ablation therapy. Without hesitation, Ms. Mai agreed. Having been treated at Fuda since 2022, she has developed deep trust in the doctors and nurses.
“If they think it’s suitable for me, I trust them,” she said.

Ozone ablation is a rapidly developing minimally invasive interventional technique in recent years. Under precise image guidance (such as DSA or CT), medical ozone is injected directly into the affected intervertebral disc. Through its combined oxidative, anti-inflammatory, and ablation effects, ozone rapidly relieves nerve compression and promotes tissue repair. With advantages including minimal invasiveness, high efficiency, safety, and low trauma, it is often referred to as a “green therapy.”
With a single injection achieving dual effects, ozone specifically oxidizes the nucleus pulposus, causing contraction and solidification of the liquefied disc material, eliminating chemical and immunogenic irritation. At the same time, it exerts strong anti-inflammatory and analgesic effects. When injected around the nerve root, radicular pain can be relieved almost immediately. Over time, the nucleus pulposus gradually shrinks and solidifies, preventing further protrusion.

During the procedure, under DSA fluoroscopic guidance, Vice President Professor Shang Jianbiao precisely positioned the target area and used a 21G fine needle to accurately access the C5/6 and C6/7 intervertebral spaces, injecting ozone at an appropriate concentration. The puncture site required only a simple adhesive dressing. Although Ms. Mai needed to lie flat for one day after the procedure and avoid moving her neck—which she found somewhat uncomfortable—she soon felt significant relief. The neck pain subsided, and she felt much lighter and more relaxed overall.

Indications for Ozone Ablation Therapy
Obvious clinical symptoms, such as persistent low back and leg pain or intermittent claudication;
Positive signs of spinal nerve compression or sensory abnormalities, such as a positive straight-leg-raising test;
Imaging confirmation of contained or simple disc herniation, with findings consistent with clinical symptoms and signs;
Poor response after more than 8 weeks of conservative treatment;
Unsatisfactory results from surgical treatment or other minimally invasive disc therapies;

Chronic low back pain unresponsive to long-term conservative treatment, without obvious nerve compression symptoms, but with imaging-confirmed disc pathology (e.g., disc bulging) at the corresponding level, and exclusion of other causes.

“Since treatment costs money anyway, why not choose a hospital where I feel comfortable and at ease?”
Over the years and through multiple hospital stays, Ms. Mai has not only received effective treatment at Fuda but also experienced genuine care and reliability. This is why she has become a “returning patient.”
Ms. Mai’s story is far from unique at Fuda. Many patients who once overcame major illnesses here choose to return when facing other health issues, coming back to this “familiar place” as trusted returning patients. This continuity of trust forms a positive cycle in the doctor-patient relationship.
From cancer treatment to geriatric pain management and long-term rehabilitation, departments across the hospital work closely together to accompany patients through every stage of their health journey. We understand that every treatment represents a unique life entrusted to us. A hospital should not only be a place of medical technology to relieve suffering, but also a reliable partner safeguarding health throughout the entire life cycle. Interdepartmental collaboration is not merely technical—it is holistic, human-centered care.
Whether you are visiting for the first time or returning as a familiar friend, what remains unchanged is our commitment to care grounded in professionalism and guided by sincerity. With medical excellence and compassion, we strive to accompany every family safely through the long river of life.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +60 19 996 4656
🌟 WhatsApp: +60 19 996 4656
🌍 Website: https://en.fudahospital.com/

07/01/2026

【微创治疗】【肺癌-冷冻消融/碘粒子植入/微血管介入】
>>>肺癌患者的福音:复大微创治疗助力患者对抗肺癌> https://hongkong.fudahospital.com/

您可以通過以下方式聯絡我們:
☎️電話: +60 19 996 4656
🌟Whatsapp: +60 19 996 4656
🌍網站: https://hongkong.fudahospital.com

Address

Level 27-05, Tower B, Pavilion Embassy, 200 Jalan Ampang
Kuala Lumpur
50450

Telephone

+60199964656

Website

https://english.fudaguangzhou.com/

Alerts

Be the first to know and let us send you an email when Fuda Cancer Hospital - Malaysia posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Fuda Cancer Hospital - Malaysia:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category